Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-164
Closed -$6K 2113
2020
Q3
$6K Buy
164
+24
+17% +$1.05K ﹤0.01% 2061
2020
Q2
$6K Buy
140
+87
+164% +$3.29K ﹤0.01% 2045
2020
Q1
$2K Hold
53
﹤0.01% 2872
2019
Q4
$2K Hold
53
﹤0.01% 2872
2019
Q3
$2K Buy
53
+27
+104% +$1.18K ﹤0.01% 2867
2019
Q2
$1K Hold
26
﹤0.01% 2984
2019
Q1
$1K Hold
26
﹤0.01% 2960
2018
Q4
$1K Buy
+26
New +$1.56K ﹤0.01% 2922
2016
Q4
Sell
-9,706
Closed -$292K 2609
2016
Q3
$292K Hold
9,706
﹤0.01% 1089
2016
Q2
$227K Sell
9,706
-376
-4% -$8.24K ﹤0.01% 1145
2016
Q1
$184K Sell
10,082
-13,056
-56% -$246K ﹤0.01% 1181
2015
Q4
$467K Buy
23,138
+6,366
+38% +$135K ﹤0.01% 941
2015
Q3
$365K Buy
16,772
+180
+1% +$4.22K ﹤0.01% 1025
2015
Q2
$386K Buy
16,592
+196
+1% +$4.92K ﹤0.01% 1054
2015
Q1
$426K Buy
16,396
+6,690
+69% +$159K ﹤0.01% 1018
2014
Q4
$214K Hold
9,706
﹤0.01% 1268
2014
Q3
$176K Sell
9,706
-4,750
-33% -$94.9K ﹤0.01% 1218
2014
Q2
$309K Hold
14,456
﹤0.01% 1023
2014
Q1
$326K Hold
14,456
﹤0.01% 1017
2013
Q4
$352K Hold
14,456
﹤0.01% 965
2013
Q3
$343K Hold
14,456
﹤0.01% 956
2013
Q2
$289K Buy
+14,456
New +$362K ﹤0.01% 962

Other funds holding SRDX

Glenmede Trust's SRDX Position: Q4 2020 in Review

Glenmede Trust sold out of Surmodics (SRDX) in Q4 2020, closing a stake of 164 shares — an estimated $6K sold.

Glenmede Trust first reported a position in SRDX in Q2 2013 and held it in 22 quarters. The position peaked at $467K in Q4 2015. 140 funds tracked by Wall St. Rank hold SRDX as of Q4 2020.

  • Glenmede Trust reported no remaining Surmodics position as of Q4 2020 after selling out during the quarter.
  • Glenmede Trust sold 164 Surmodics shares in Q4 2020, an estimated $6K.
  • Glenmede Trust first reported a position in Surmodics in Q2 2013 and held it in 22 quarters.
  • Glenmede Trust's Surmodics position peaked at $467K in Q4 2015.
  • 140 funds tracked by Wall St. Rank held Surmodics as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.